Study to Assess the Pharmacodynamic Effects of Unfractionated Heparin (UFH) in Healthy Volunteers With and Without Bendavia
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
This will be a phase 1 randomized, double-blind crossover trial enrolling approximately 12
healthy volunteers to assess whether intravenous (IV) UFH and IV Bendavia administered
together have any significant impact on the pharmacodynamic effects of UFH and the
pharmacokinetics of Bendavia.